A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas

Br J Cancer. 1985 Feb;51(2):283-9. doi: 10.1038/bjc.1985.41.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antibodies, Neoplasm / biosynthesis
  • Antigens, Neoplasm / analysis*
  • Brain Neoplasms / immunology
  • Brain Neoplasms / therapy*
  • Cell Line
  • Combined Modality Therapy
  • Female
  • Glioma / immunology
  • Glioma / therapy*
  • HLA Antigens / analysis*
  • Humans
  • Immunotherapy*
  • Male
  • Middle Aged

Substances

  • Antibodies, Neoplasm
  • Antigens, Neoplasm
  • HLA Antigens